Colorectal Cancer Awareness

Total Pharmacy Care for Colorectal Cancer Patients

March is Colorectal Cancer Awareness Month and with many treatment options, expert clinical support, and our excellent OncoAdvocate® funding Team, we provide all-around and focused pharmacy care for colorectal cancer patients.

Our OncoAdvocates can even help explore funding opportunities for new Xeloda patients who are no longer eligible for the Genentech Free Drug Program. We secured over $4.8+ million in foundational assistance for colorectal cancer patients alone in 2022, including those on medications such as Xeloda® and Capecitabine.

92% of our colorectal cancer patients paid less than $50 for their last dispense

Currently, 78% of our colorectal cancer patient’s copays are covered by funding sources or copay cards

Facts and Stats for Colorectal Cancer

  • Most colorectal cancers start as a growth or polyp on the inner lining of the colon or rectum
  • Colorectal cancer is the fourth most common cancer diagnosed in the United States with an estimate of 106,970 new cases in 20231
  • Type 2 diabetes increases your risk because type 2 diabetes and colorectal cancer share some of the same risk factors such as obesity and physical inactivity2

Why Choose Onco360?

  • As a specialty pharmacy 100% focused on cancer, we will act as your advocate with your physician, insurance company, and others involved in your treatment
  • Timing is crucial when it comes to cancer treatment. Our goal, without prior authorization or funding issues, is to have your medication delivered within 3-4 days. We even provide complimentary overnight shipping to your doorstep.
  • We will make sure you understand your medications, their dosage, and any potential side effects. Our clinicians and pharmacists are on call 24/7 if you have any issues at 877.662.6633.

Onco360 has access to Capecitabine and many other medications
to treat colorectal cancer**

 

Adrucil® (fluorouracil)

Avastin® (bevacizumab)

Braftovi® (encorafenib)

Camptosar® (irinotecan)

Cyramza® (ramucirumab)

Eloxatin® (oxaliplatin)

Erbitux® (cetuximab)

Fruzaqla (fruquintinib)

Jemperli (dostarlimab)

Keytruda® (pembrolizumab)

Leucovorin

Lonsurf® (trifluridine-tipiracil)

Opdivo® (nivolumab)

Retevmo® (selpercatinib)

Rozlytrek® (entrectinib)

Stivarga® (regorafenib)

Tukysa® (tucatinib)

Vectibix® (panitumumab)

Xeloda® (capecitabine)

Yervoy® (ipilimumab)

Zaltrap® (ziv-aflibercept)

**This list is a small portion of the comprehensive medications Onco360 can provide.

If you are a provider and would like to refer to Onco360, click here for order forms.

Helpful Patient Resources

If you would like to read further about colorectal cancer or find support in your area, below are a few recommended resources:

1https://www.cancer.org/cancer/colon-rectal-cancer/about/key-statistics.html

2https://www.cancer.org/cancer/colon-rectal-cancer/causes-risks-prevention/risk-factors.html

*Third party survey data provided by MMIT for Independent Specialty Pharmacies (Oncology). Report dates Q3 and Q4 2021.